BC Partners Nears Sale of Synthon to Goldman Asset Arm

Estimated read time 1 min read


BC Partners is nearing a deal to sell Dutch generic drugmaker Synthon International Holding BV to Goldman Sachs Asset Management, according to people familiar with the matter.

Source link

You May Also Like

More From Author

+ There are no comments

Add yours